Lauren A Beslow Selected Research

Contraindications

9/2021

Endovascular and thrombolytic treatment eligibility in childhood arterial ischemic stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lauren A Beslow Research Topics

Disease

7	Stroke (Strokes) 11/2021 - 07/2014
6	Infarction (Infarctions) 02/2020 - 04/2011
5	Ischemic Stroke 09/2021 - 01/2016
4	Brain Edema (Cerebral Edema) 11/2019 - 02/2016
4	Edema (Dropsy) 11/2019 - 02/2016
2	Hemorrhage 01/2018 - 01/2017
1	Craniosynostoses (Craniosynostosis) 01/2022
1	Neurologic Manifestations (Neurological Manifestations) 09/2021
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 08/2021
1	Neoplasms (Cancer) 10/2020
1	Thrombosis (Thrombus) 10/2020
1	Epilepsy (Aura) 10/2018
1	Wounds and Injuries (Trauma) 01/2017
1	Hydrocephalus (Hydrocephaly) 01/2017
1	Encephalocele (Encephalocele, Frontal) 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2016
1	Hypertension (High Blood Pressure) 03/2016
1	Renal Insufficiency (Renal Failure) 03/2016
1	Myocarditis (Carditis) 10/2014
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 10/2014
1	Cardiac Arrhythmias (Arrythmia) 10/2014
1	Brain Neoplasms (Brain Tumor) 04/2013

Drug/Important Bio-Agent (IBA)

5	Glyburide (Glibenclamide)FDA LinkGeneric 02/2020 - 02/2016
1	Biomarkers (Surrogate Marker)IBA 11/2019
1	Anticonvulsants (Antiepileptic Drugs)IBA 10/2018
1	Matrix Metalloproteinases (MMPs)IBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2018
1	Warfarin (Coumadin)FDA LinkGeneric 01/2017
1	Opioid Analgesics (Opioids)IBA 01/2017
1	ElectrolytesIBA 03/2016
1	Blood Glucose (Blood Sugar)IBA 01/2016
1	Intravenous Immunoglobulins (IVIG)FDA Link 10/2014
1	Tissue Plasminogen Activator (Alteplase)FDA Link 07/2014

Therapy/Procedure

7	Therapeutics 09/2021 - 04/2011
2	Length of Stay 01/2018 - 03/2016
1	Sutures (Suture) 01/2022
1	Thrombectomy 11/2021
1	Contraindications 09/2021
1	Drug Therapy (Chemotherapy) 10/2020
1	Secondary Prevention 01/2019
1	Craniotomy 01/2017
1	Decompressive Craniectomy 10/2016
1	Transjugular Intrahepatic Portasystemic Shunt 07/2014
1	Thrombolytic Therapy 07/2014
1	Cranial Irradiation 04/2013